E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
[Evaluation of fatigue by using acceleration plethysmography].
Yamaguti, Kouzi · Nihon rinsho. Japanese journal of clinical medicine · 2007
Quick Summary
Researchers tested a new device called acceleration plethysmography to measure fatigue in ME/CFS patients. This device tracks tiny blood vessel changes and nervous system activity in the fingertip. The study found that fatigue levels were connected to specific patterns in these measurements, suggesting this tool might help doctors objectively measure ME/CFS fatigue in the future.
Why It Matters
ME/CFS lacks reliable objective biomarkers for fatigue severity, making diagnosis and treatment monitoring challenging. If acceleration plethysmography can objectively quantify autonomic dysfunction and fatigue level, it could improve clinical assessment and potentially serve as an outcome measure in future treatment trials.
Observed Findings
- Acceleration plethysmography showed relatively dominant sympathetic nervous system activity in ME/CFS patients
- Time-series fluctuation in acceleration plethysmography data was decreased (lower complexity) in patient measurements
- A relationship was identified between the degree of fatigue and changes in acceleration plethysmography patterns
- Autonomic nervous system alterations were detectable and measurable via this non-invasive technique
Inferred Conclusions
- Autonomic nervous system dysfunction, particularly sympathetic dominance, is associated with fatigue in ME/CFS
- Acceleration plethysmography may serve as a useful objective tool for evaluating and quantifying fatigue severity in ME/CFS
- Reduced complexity in cardiovascular dynamics reflects or accompanies the fatigued state in these patients
Remaining Questions
- How does acceleration plethysmography performance compare to other autonomic assessment methods (heart rate variability, tilt table testing)?
- Are the observed sympathetic changes specific to ME/CFS or do they occur in other fatigue-related conditions?
- Can this measurement predict treatment response or disease progression over time?
What This Study Does Not Prove
This study does not prove that acceleration plethysmography changes *cause* fatigue or that they are specific to ME/CFS rather than other conditions. The abstract does not clarify whether the observed autonomic changes are unique to ME/CFS or reproducible in other patient populations. Correlation between measurements and fatigue does not establish causation or clinical utility in practice.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- PMID
- 17561694
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →